The Landscape of GLP-1 Prescriptions in Germany: A Comprehensive GuideThe pharmaceutical landscape in Germany has gone through a considerable shift over the last 2 years, driven mainly by the international surge in need for GLP-1 (Glucagon-like peptide-1) receptor agonists. Initially established to treat Type 2 diabetes, these medications have acquired
